Official UK procurement notice
NHS National Framework for Transition products commencing 1 May 2024
Authority: NHS England (Central government)
Re-procurement openNHS National Framework for Lenvatinib · bids close
What is being bought2 lots · detail below
Published requirement descriptionProject title: NHS National Framework for Transition products commencing 1 May 2024<br/>Offer reference number: CM/TNS/05/2024<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/05/2024/01<br/>Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)<br/>Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)<br/><br/>CM/TNS/05/2024/02<br/>Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 16 bids on the busiest of 2 lots · 12 suppliers appointed
- Framework period
- 1 yr 5 mo from 1 May 2024
Lots and requirements (2)Procurement structure
2 lots · all with a published valueLot #1CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, TrabectedinAwardedPublished value£137,997,000
CM/TNS/05/2024/01<br/>Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)<br/>Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months) <br/>Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months) Additional information: CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin<br/>Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months)<br/>Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)
Lot #2CM/TNS/05/2024/02 - Apixaban, SapropterinAwardedPublished value£41,395,000
CM/TNS/05/2024/02<br/>Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months) <br/>Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months) Additional information: CM/TNS/05/2024/02 - Apixaban, Sapropterin<br/>Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months)<br/>Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “NHS National Framework for Transition products commencing 1 May 2024” is a framework: the contest is a place on its panel, not a single contract.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 16 Feb 2024, 11:14 GMT
- Last source update
- 24 Apr 2024, 10:47 BST
- Award evaluation window
- 18 Mar 2024 – …
- Authority reference
CM/TNS/05/2024- FTS notice number
2024/S 000-013260- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-043aa8Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
Publisher note: RESPONDING TO THIS NOTICE;<br/>Any supplier may be disqualified who does not respond to the following in the requisite manner:<br/>1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.uk<br/>Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:<br/>1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:<br/>- agree to the user agreement<br/>- populate company details<br/>1.2) Once registered, candidates must register interest as follows:<br/>- log to the portal<br/>- select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select<br/>- review opportunity details and click "Register Interest"<br/>- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)<br/>1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at [email protected] or by calling 0800 9956035 for technical assistance when completing responses.<br/>2) General supplier information.<br/>To manage and assess supplier information the Contracting Authority requests candidates provide their<br/>company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:<br/>2.1) If not already registered (the previous sid4gov password, login and details will still<br/>be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk<br/>and select "Register" at the top of the page.<br/>Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B.<br/>Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on the system.<br/>2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.<br/>D&B data will be supplied automatically by D&B.<br/>2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the<br/>message function on the website.<br/>OTHER CONTRACTING AUTHORITIES<br/>The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Appointment period ends
- 18 Mar 2024, 13:00 GMT
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bids opened
- 18 Mar 2024, 13:00 GMT
Timeline
18 Mar 2024 → 16 Jun 2024 · 5 dates- Admission / appointment period endsperiod end, not a bid countdown18 Mar 2024, 13:00 GMT
- Bids opened18 Mar 2024, 13:00 GMT
- Notice published24 Apr 2024, 10:47 BST
- Contract starts1 May 2024, 00:00 BST
- Bids must remain valid until16 Jun 2024, 23:59 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete24 Apr 2024, 10:47 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast14 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
All 14 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.
Dimethyl fumarate, Teriflunomide, Trabectedin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2025
- Status
- active
Apixaban, Sapropterin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2024
- Status
- active
Apixaban, Sapropterin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2024
- Status
- active
Apixaban, Sapropterin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2024
- Status
- active
Apixaban, Sapropterin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2024
- Status
- active
Apixaban, Sapropterin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2024
- Status
- active
Dimethyl fumarate, Teriflunomide, Trabectedin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2025
- Status
- active
Dimethyl fumarate, Teriflunomide, Trabectedin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2025
- Status
- active
Dimethyl fumarate, Teriflunomide, Trabectedin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2025
- Status
- active
Dimethyl fumarate, Teriflunomide, Trabectedin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2025
- Status
- active
Dimethyl fumarate, Teriflunomide, Trabectedin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2025
- Status
- active
Dimethyl fumarate, Teriflunomide, Trabectedin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2025
- Status
- active
Dimethyl fumarate, Teriflunomide, Trabectedin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2025
- Status
- active
Apixaban, Sapropterin
- Signed
- 18 Apr 2024
- Value
- ceiling above
- Period
- … – 30 Sept 2024
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · CM/TNS/05/2024/01 - Dimethyl fumarate, Teriflunomide, Trabectedin | 16bids · 16 electronic · 16 from abroad | 9 | — | — |
| 2 · CM/TNS/05/2024/02 - Apixaban, Sapropterin | 9bids · 9 electronic · 9 from abroad | 5 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Framework contractors & participating bidders
12 commercial parties on the notice- Aspire Pharma LimitedFramework contractor
- Celix Pharma Ltd.Framework contractor
- Dr.Reddy's Laboratories (UK) LimitedFramework contractor
- Glenmark Pharmaceuticals Europe LimitedFramework contractor
- Immedica Pharma ABFramework contractor
- Kent Pharma LtdFramework contractor
- LogixX Pharma LtdFramework contractor
- MylanFramework contractor
- Sandoz LtdFramework contractor
- Selective Supplies Ltd.Framework contractor
Show 2 more suppliers
- Teva UK LimitedFramework contractor
- Thornton and Ross LtdFramework contractor
Official documents & specifications (1)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria